GSA Capital Partners’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $208K | Sell |
392
-301
| -43% | -$139K | 0.01% | 1502 |
|
|
2026
Q1 | $333K | Buy |
+693
| New | +$355K | 0.02% | 1188 |
|
|
2025
Q3 | – | Sell |
-710
| Closed | -$223K | – | 1920 |
|
|
2025
Q2 | $223K | Buy |
+710
| New | +$213K | 0.02% | 1450 |
|
|
2024
Q4 | – | Sell |
-826
| Closed | -$276K | – | 1853 |
|
|
2024
Q3 | $276K | Buy |
+826
| New | +$314K | 0.02% | 1259 |
|
|
2024
Q2 | – | Sell |
-611
| Closed | -$247K | – | 1882 |
|
|
2024
Q1 | $247K | Buy |
+611
| New | +$215K | 0.02% | 1310 |
|
|
2023
Q3 | – | Sell |
-1,908
| Closed | -$458K | – | 1750 |
|
|
2023
Q2 | $458K | Sell |
1,908
-3,208
| -63% | -$666K | 0.05% | 796 |
|
|
2023
Q1 | $962K | Buy |
5,116
+2,970
| +138% | +$614K | 0.1% | 334 |
|
|
2022
Q4 | $456K | Buy |
+2,146
| New | +$429K | 0.06% | 669 |
|
|
2022
Q3 | – | Sell |
-4,661
| Closed | -$698K | – | 1741 |
|
|
2022
Q2 | $698K | Buy |
+4,661
| New | +$675K | 0.1% | 304 |
|
|
2022
Q1 | – | Sell |
-2,413
| Closed | -$525K | – | 1655 |
|
|
2021
Q4 | $525K | Buy |
2,413
+904
| +60% | +$189K | 0.07% | 564 |
|
|
2021
Q3 | $286K | Buy |
+1,509
| New | +$275K | 0.03% | 1054 |
|
|
2021
Q1 | – | Sell |
-2,137
| Closed | -$297K | – | 1325 |
|
|
2020
Q4 | $297K | Sell |
2,137
-6,336
| -75% | -$799K | 0.05% | 741 |
|
|
2020
Q3 | $947K | Buy |
+8,473
| New | +$980K | 0.16% | 113 |
|
|
2020
Q2 | – | Sell |
-8,372
| Closed | -$614K | – | 910 |
|
|
2020
Q1 | $614K | Sell |
8,372
-7,439
| -47% | -$646K | 0.15% | 85 |
|
|
2019
Q4 | $1.33M | Buy |
15,811
+2,284
| +17% | +$177K | 0.15% | 103 |
|
|
2019
Q3 | $1.14M | Sell |
13,527
-19,315
| -59% | -$1.46M | 0.15% | 119 |
|
|
2019
Q2 | $2.15M | Sell |
32,842
-19,131
| -37% | -$1.1M | 0.24% | 33 |
|
|
2019
Q1 | $3.06M | Buy |
51,973
+3,573
| +7% | +$213K | 0.31% | 26 |
|
|
2018
Q4 | $2.56M | Sell |
48,400
-46,320
| -49% | -$2.54M | 0.3% | 34 |
|
|
2018
Q3 | $5.67M | Buy |
94,720
+9,520
| +11% | +$521K | 0.31% | 9 |
|
|
2018
Q2 | $3.66M | Buy |
85,200
+43,300
| +103% | +$1.75M | 0.18% | 68 |
|
|
2018
Q1 | $1.46M | Buy |
41,900
+22,000
| +111% | +$804K | 0.08% | 440 |
|
|
2017
Q4 | $722K | Sell |
19,900
-8,300
| -29% | -$291K | 0.04% | 759 |
|
|
2017
Q3 | $900K | Buy |
28,200
+17,900
| +174% | +$547K | 0.06% | 592 |
|
|
2017
Q2 | $299K | Buy |
+10,300
| New | +$289K | 0.02% | 1278 |
|
|
2017
Q1 | – | Sell |
-9,370
| Closed | -$338K | – | 1898 |
|
|
2016
Q4 | $338K | Buy |
+9,370
| New | +$312K | 0.02% | 1263 |
|
Other funds holding MEDP
WA
GSA Capital Partners's MEDP Position: Q2 2026 in Review
GSA Capital Partners reduced its Medpace (MEDP) stake by 43% in Q2 2026, selling an estimated $139K and leaving 392 shares worth $208K. The position accounts for 0.01% of the portfolio, ranked #1502.
GSA Capital Partners first reported a position in MEDP in Q4 2016 and has held it in 26 quarters since. The position peaked at $5.67M in Q3 2018. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- GSA Capital Partners held 392 shares of Medpace worth $208K as of Q2 2026.
- GSA Capital Partners sold 301 Medpace shares in Q2 2026, an estimated $139K.
- Medpace made up 0.01% of GSA Capital Partners's portfolio in Q2 2026, its #1502 holding.
- GSA Capital Partners first reported a position in Medpace in Q4 2016 and has held it in 26 quarters since.
- GSA Capital Partners's Medpace position peaked at $5.67M in Q3 2018.
- 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.